Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$79.4 - $116.36 $289,968 - $424,946
3,652 New
3,652 $291,000
Q3 2020

Nov 16, 2020

SELL
$55.23 - $79.93 $212,469 - $307,490
-3,847 Closed
0 $0
Q2 2020

Oct 22, 2020

BUY
$30.2 - $56.98 $116,179 - $219,202
3,847 New
3,847 $214,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Arabesque Asset Management LTD Portfolio

Follow Arabesque Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Arabesque Asset Management LTD with notifications on news.